Mitchell & Pahl Private Wealth’s Guardant Health GH Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,624	Closed	-$203K	–	168
2021 Q3	$203K	Sell	1,624 -20	-1%	-$2.38K	0.15%	153
2021 Q2	$204K	Hold	1,644	–	–	0.15%	151
2021 Q1	$251K	Sell	1,644 -9	-0.5%	-$1.36K	0.19%	130
2020 Q4	$213K	Buy	+1,653	New	+$190K	0.18%	139

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mitchell & Pahl Private Wealth's GH Position: Q4 2021 in Review

Mitchell & Pahl Private Wealth sold out of Guardant Health (GH) in Q4 2021, closing a stake of 1,624 shares — an estimated $203K sold.

Mitchell & Pahl Private Wealth first reported a position in GH in Q4 2020 and held it in 4 quarters. The position peaked at $251K in Q1 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

Mitchell & Pahl Private Wealth reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
Mitchell & Pahl Private Wealth sold 1,624 Guardant Health shares in Q4 2021, an estimated $203K.
Mitchell & Pahl Private Wealth first reported a position in Guardant Health in Q4 2020 and held it in 4 quarters.
Mitchell & Pahl Private Wealth's Guardant Health position peaked at $251K in Q1 2021.
396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q4 2021, filed 19 Jan 2022.